-
@ Yahoo! Finance - by layer3.news
2025-05-28 21:53:58
nostr:nprofile1qy3hwumn8ghj7un9d3shjtt5v4ehgmn9wshxkwrn9ekxz7t9wgejumn9waesqgr8g2hyzql5lt4cxfjdj40hgtu6vydvsqvsesqy8canygcce3lwvyyapkyy
✍️ The high demand and prices of GLP-1 weight-loss drugs, such as Ozempic and Wegovy, raise concerns about their affordability for U.S. healthcare consumers.
👉 GLP-1 drugs are in high demand and short supply in the U.S.
👉 Prices remain high despite the FDA declaring shortages over
👉 Affordability of these drugs is a concern for healthcare consumers
#U.S. #health
nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqy3hwumn8ghj7un9d3shjtt5v4ehgmn9wshxkwrn9ekxz7t9wgejumn9waesqgqdu6hcycnglv3up44sfg73ufh0mn8dsumu6k9dpz89wcmkymph0cjywnlh